Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 69Active not recruiting 51Completed 36Terminated 8Not yet recruiting 8Enrolling by invitation 2Suspended 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Neoplasms 1

Interventions

Educational Status 7Standard of Care 5Interviews as Topic 5Cisplatin 5Blood Specimen Collection 5Oxaliplatin 4Surveys and Questionnaires 3Surgical Procedures, Operative 3Specimen Handling 3Patient Navigation 3Observation 3Nivolumab 3Methods 3Magnetic Resonance Imaging 3Fluorouracil 3Early Intervention, Educational 3Biopsy 3toripalimab 2sacituzumab govitecan 2pembrolizumab 2lenvatinib 2Transcutaneous Electric Nerve Stimulation 2Radiosurgery 2Practice Guidelines as Topic 2Platinum Compounds 2Paclitaxel 2Music Therapy 2Magnetic Resonance Spectroscopy 2Leucovorin 2Letrozole 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Enrolling by invitation × Letrozole × 1 year × Clear all
NCT06650748 2026-03-17

NeoMARS

Peking University

Phase 2 Enrolling by invitation
100 enrolled
Breast

Breast Neoplasms

NCT05645536 2026-01-12

Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study

Tolmar Inc.

Phase 3 Enrolling by invitation
250 enrolled
Breast

Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡